Cargando…

Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis

Pembrolizumab is an immune checkpoint inhibitor used in many different cancers. Several immune-related adverse events (irAEs) have been associated with pembrolizumab, including toxic epidermal necrolysis. Here, we are presenting a patient with non-small cell lung cancer that developed toxic epiderma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kian, Waleed, Zemel, Melanie, Elobra, Firas, Sharb, Adam A., Levitas, Dina, Assabag, Yarden, Alguayn, Farouq, Yakobson, Alexander, Rouvinov, Keren, Fuchs, Lior
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670350/ https://www.ncbi.nlm.nih.gov/pubmed/34321417 http://dx.doi.org/10.1097/CAD.0000000000001162

Ejemplares similares

1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
por: Zemel, M., et al.
Publicado: (2021)

Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study
por: Kian, Waleed, et al.
Publicado: (2022)

Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer
por: Kian, Waleed, et al.
Publicado: (2020)

Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer
por: Kian, Waleed, et al.
Publicado: (2020)

Pembrolizumab-Induced Toxic Epidermal Necrolysis
por: Borg, Luca, et al.
Publicado: (2022)

Pembrolizumab-induced toxic epidermal necrolysis: case report
por: Chow, Kar Ven Cavan, et al.
Publicado: (2022)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
por: Qiu, Connie, et al.
Publicado: (2020)

Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
por: Boroda, Konstantin, et al.
Publicado: (2015)

Treatment of Toxic Epidermal Necrolysis With Immunoglobulins in a Burn Center
por: Cachafeiro Fuciños, L, et al.
Publicado: (2015)

Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
por: Eldani, Céline, et al.
Publicado: (2023)

Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)

Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)

Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib
por: Kian, Waleed, et al.
Publicado: (2023)

Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
por: Saavedra, Carlos, et al.
Publicado: (2012)

Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination
por: Shalata, Walid, et al.
Publicado: (2022)

Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis and Sepsis
por: Alves, Daniela Dias, et al.
Publicado: (2016)

Carbamzepine-induced toxic epidermal necrolysis
por: Chowta, Nithyananda K., et al.
Publicado: (2011)

Ofloxacin-induced toxic epidermal necrolysis
por: Gupta, Gaurang
Publicado: (2014)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Rapidly Developing Toxic Epidermal Necrolysis
por: Poulsen, Viktoria Oline Barrios, et al.
Publicado: (2013)

Toxic epidermal necrolysis in hemodialysis patient
por: Mateti, Uday Venkat, et al.
Publicado: (2015)

Early Manifestations of Toxic Epidermal Necrolysis
por: Chapman, James, et al.
Publicado: (2017)

Fulvestrant-induced toxic epidermal necrolysis
por: Morales-Conde, Macarena, et al.
Publicado: (2019)

Immune-Mediated Toxic Epidermal Necrolysis
por: Keerty, Dinesh, et al.
Publicado: (2020)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Toxic Epidermal Necrolysis Secondary to Metronidazole
por: Ali, Junaid, et al.
Publicado: (2021)

Pneumonia caused by toxic epidermal necrolysis
por: Doyle, Dominic, et al.
Publicado: (2022)

Multidisciplinary Treatment in Toxic Epidermal Necrolysis
por: Surowiecka, Agnieszka, et al.
Publicado: (2023)

Levofloxacin-Induced Toxic Epidermal Necrolysis
por: Khan, Andeebia A, et al.
Publicado: (2023)

Phenytoin-Induced Toxic Epidermal Necrolysis
por: Tunuguntla, Mounika Nagarani, et al.
Publicado: (2023)

Lamotrigine-associated toxic epidermal necrolysis
por: Farooq, Omair, et al.
Publicado: (2023)

Combination of Infliximab and High-Dose Intravenous Immunoglobulin for Toxic Epidermal Necrolysis: Successful Treatment of an Elderly Patient
por: Patmanidis, Konstantinos, et al.
Publicado: (2012)

Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 – 2015
por: Sweileh, Waleed M.
Publicado: (2017)

Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
por: Rouvinov, Keren, et al.
Publicado: (2019)

Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010)

Skin Detachment and Regrowth in Toxic Epidermal Necrolysis
por: Feldmeyer, Laurence, et al.
Publicado: (2010)

Toxic epidermal necrolysis: review of 15 cases
por: Oueslati, H, et al.
Publicado: (2009)

Toxic Epidermal Necrolysis - A Case Report
por: Stătescu, Laura, et al.
Publicado: (2017)

Important Points in Toxic Epidermal Necrolysis Management
por: Al-Shaqsi, Sultan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_olsjn7htdbtp6d657jcntd3k86